Literature DB >> 18927332

Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an alphavbeta3 integrin-targeted fluorochrome.

Jens Waldeck1, Florian Häger, Carsten Höltke, Christian Lanckohr, Angelika von Wallbrunn, Giovanni Torsello, Walter Heindel, Gregor Theilmeier, Michael Schäfers, Christoph Bremer.   

Abstract

UNLABELLED: Macrophages play an important role during the development and progression of atherosclerotic plaques. alphavbeta3 integrins are highly expressed by macrophages; thus, targeting alphavbeta3 may allow targeting of culprit macrophage-loaded atherosclerotic lesions in vivo.
METHODS: An alphavbeta3-targeted Arg-Gly-Asp (RGD) peptide was labeled with the cyanine 5.5 (Cy 5.5) dye and applied to image atherosclerotic plaques in apolipoprotein E-deficient mice.
RESULTS: The peptide-dye conjugate binds to alphavbeta3 integrin-positive RAW264.7 macrophages with high affinity. Competition experiments confirmed binding specificity of the probe. A significant fluorochrome accumulation in atherosclerotic plaques was demonstrated 24 h after injection by fluorescence reflectance imaging, which was blocked with high efficiency by competition with the unlabeled peptide. Conversely, the nonconjugated dye revealed only a minor fluorescence signal in the plaques. Fluorescence microscopy revealed colocalization of the probe with macrophages in the plaque of a mouse model for accelerated atherosclerosis, which was corroborated in human carotid artery specimens. In addition to macrophage-associated signals, binding of the probe to the neointima or elastica of the arteries was observed.
CONCLUSION: RGD-Cy 5.5, combined with near-infrared optical imaging methods, allows the specific imaging of alphavbeta3-integrin expression on macrophages recruited to vascular lesions and may serve to estimate macrophage-bound inflammatory activity of atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18927332     DOI: 10.2967/jnumed.108.052514

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  24 in total

1.  RGD-conjugated human ferritin nanoparticles for imaging vascular inflammation and angiogenesis in experimental carotid and aortic disease.

Authors:  Toshiro Kitagawa; Hisanori Kosuge; Masaki Uchida; Monica M Dua; Yasunori Iida; Ronald L Dalman; Trevor Douglas; Michael V McConnell
Journal:  Mol Imaging Biol       Date:  2012-06       Impact factor: 3.488

2.  Human ferritin cages for imaging vascular macrophages.

Authors:  Masahiro Terashima; Masaki Uchida; Hisanori Kosuge; Philip S Tsao; Mark J Young; Steven M Conolly; Trevor Douglas; Michael V McConnell
Journal:  Biomaterials       Date:  2010-11-11       Impact factor: 12.479

Review 3.  Peptides and peptide hormones for molecular imaging and disease diagnosis.

Authors:  Seulki Lee; Jin Xie; Xiaoyuan Chen
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

4.  Full density fluorescence molecular tomography (FD-FMT) based on a dichroic mirror.

Authors:  Hao Yang; Xianjin Dai; Huabei Jiang
Journal:  Appl Opt       Date:  2018-09-20       Impact factor: 1.980

5.  Integrin-targeted imaging of inflammation in vascular remodeling.

Authors:  Mahmoud Razavian; Ravi Marfatia; Heloise Mongue-Din; Sina Tavakoli; Albert J Sinusas; Jiasheng Zhang; Lei Nie; Mehran M Sadeghi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-09-22       Impact factor: 8.311

6.  Atherosclerotic plaque uptake of a novel integrin tracer ¹⁸F-Flotegatide in a mouse model of atherosclerosis.

Authors:  Helen Su; Natalia Gorodny; Luis Felipe Gomez; Umesh B Gangadharmath; Fanrong Mu; Gang Chen; Joseph C Walsh; Katrin Szardenings; Daniel S Berman; Hartmuth C Kolb; Balaji K Tamarappoo
Journal:  J Nucl Cardiol       Date:  2014-03-14       Impact factor: 5.952

7.  Diet intervention reduces uptake of αvβ3 integrin-targeted PET tracer 18F-galacto-RGD in mouse atherosclerotic plaques.

Authors:  Antti Saraste; Iina Laitinen; Eliane Weidl; Moritz Wildgruber; Axel W Weber; Stephan G Nekolla; Gabriele Hölzlwimmer; Irene Esposito; Axel Walch; Pia Leppänen; Irina Lisinen; Peter B Luppa; Seppo Ylä-Herttuala; Hans-Jürgen Wester; Juhani Knuuti; Markus Schwaiger
Journal:  J Nucl Cardiol       Date:  2012-04-20       Impact factor: 5.952

Review 8.  Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins.

Authors:  Shuang Liu
Journal:  Bioconjug Chem       Date:  2015-08-03       Impact factor: 4.774

Review 9.  Optical and multimodality molecular imaging: insights into atherosclerosis.

Authors:  Farouc A Jaffer; Peter Libby; Ralph Weissleder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-04-09       Impact factor: 8.311

Review 10.  Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency.

Authors:  Shuang Liu
Journal:  Bioconjug Chem       Date:  2009-12       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.